Related Experiment Video
Updated: Jun 21, 2026

Automated Modular High Throughput Exopolysaccharide Screening Platform Coupled with Highly Sensitive Carbohydrate Fingerprint Analysis
Published on: April 11, 2016
Structural characterization and immunomodulatory activity of an exopolysaccharide isolated from Bifidobacterium
Ye Chen1, Pei Li2, Wenyi Huang1
1School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Panyu District, No. 232, Waihuan East Road, Guangzhou, Guangdong Province 510006, China.
Abstract:
Bifidobacterium adolescentis is a key probiotic that has been proven to possess various bioactivities. A water-soluble heteropolysaccharide (BEP-1A) was isolated from the probiotic and systematically investigated for the first time. The molecular weight of BEP-1A was calculated to be 9.69 × 106 Da. Combined with monosaccharide composition, Fourier transform infrared (FT-IR) spectroscopy, methylation and nuclear magnetic resonance (NMR) analysis, BEP-1A was composed of mannose, glucose and galactose at a molar ratio of 0.11⁚4.30⁚1.32. The backbone included β-1,2-Glcp, β-1,3-Glcp, α-1,4-Glcp, α-1,4-Galp, α-1,6-Galp and α-1,3-Manp, with the branch at the O-2 position of α-1,6-Galp, consisting of α-1,2-Galp and α-1-Glcp. Moreover, a filamentous structure of BEP-1A was detected by scanning electron microscopy (SEM). BEP-1A presented high thermal stability based on thermogravimetric analysis (TGA). X-ray diffractometry (XRD) results revealed that BEP-1A was an amorphous molecule without a crystal structure. Furthermore, BEP-1A significantly increased the viability of RAW 264.7 macrophages, improved phagocytosis, and promoted the secretion of nitric oxide (NO), reactive oxygen species (ROS), tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6), interleukin-1β (IL-1β) and inducible nitric oxide synthase (iNOS). BEP-1A was also found to induce the nuclear translocation of the NF-κB subunit p65 and upregulate the phosphorylation of p65 and IκB-α, which suggested that the NF-κB pathway was involved in the BEP-1A-induced immunomodulatory effect. Overall, this study provides a theoretical basis for the development of BEP-1A as an immunomodulator in pharmaceuticals and functional foods.

